20 Molecular Diagnostics Companies to Watch
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
Immune System Gene Could Be Prognostic Marker for CRC
The gene, CCR4, was present in higher levels in patients with a good prognosis, even in those diagnosed with late stage colorectal cancer.
10 Liquid Biopsy Companies in the Money
10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
FDA Sends Warning Letter to Inova Over Pharmacogenomics Test
The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.
PerkinElmer, Helix Partner to Launch Genetic Screening Test
The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.
Wearable Data Revolution
There is no doubt the age of wearable monitors is upon us. Sales of physical activity monitors have increased dramatically from 15 million in...
10 Countries in 100K Genome Club
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Five-Year Super Successes in Genomics and Precision Medicine
Multidimensional, computationally rich approaches represent the next wave of innovation, taking personalized medicine to the next level, while demanding more of practitioners, who in...
New AACR President Elaine Mardis Talks Precision Medicine, Cancer Research with Clinical OMICs
A leader in cancer genomics research, new AACR president recaps her research over the past five years and looks ahead to what advances my lie ahead.
LabCorp’s Covance to Offer Services via Mission Bio’s Tapestri Platform
LabCorp’s Covance Drug Development business will be the first global contract research organization to offer services on Mission Bio’s Tapestri Platform for single-cell DNA genomics.
